Breaking Down North Huajin Chemical Industries Co.,Ltd Financial Health: Key Insights for Investors

Facing a mixed picture that every investor should parse closely, North Huajin Chemical reported H1 2025 revenue of 20.104 billion yuan (down 5.01% YoY) and a TTM revenue of 33.54 billion yuan (a steep 26.37% decline year-over-year), while its market capitalization rose to 8.27 billion yuan as of October 22, 2025 (up 36.05% YoY) - juxtaposed with profitability pressures including a H1 2025 net loss attributable to shareholders of 989 million yuan and TTM EPS of -1.44 yuan, negative ROA (-6.06%) and ROE (-21.30%), a debt-to-equity ratio near 1.46 amid total assets of 27.37 billion and liabilities of 16.25 billion, nearly neutral net debt with cash reserves around 8.08 billion against total debt of 8.14 billion, healthy free cash flow of 2.78 billion and operating cash flow gains (Q2 2025 cash from operations 2.47 billion, up 132.96% YoY), attractive valuation metrics such as a P/S of 0.24 and P/B of 0.79, plus a strategic growth catalyst in a >$10 billion joint venture with Aramco - explore the detailed revenue breakdowns, liquidity metrics, valuation signals and risk factors in the sections that follow.

North Huajin Chemical Industries Co.,Ltd (000059.SZ) - Revenue Analysis

• H1 2025 revenue: 20.104 billion yuan (-5.01% YoY)
• Q2 2025 revenue: 10.943 billion yuan (-6.58% YoY)
• TTM revenue as of Jun 2025: 33.54 billion yuan (-26.37% YoY)
• Full-year 2024 revenue: 34.60 billion yuan (-25.02% vs. 2023)
• Revenue per share (TTM ending Jun 2025): 21.01 yuan (-19.70% over 12 months)
• Market capitalization (Oct 22, 2025): 8.27 billion yuan (+36.05% YoY)

• Implication: revenue trajectory shows a pronounced annual contraction (≈25-26% range) with more moderate sequential quarterly weakness in H1 2025.
• Valuation signal: market cap rising (+36.05% YoY to 8.27 billion yuan) amid falling revenues suggests either market optimism on recovery, asset/restructuring re-rating, or external factors affecting share price.

North Huajin Chemical Industries Co.,Ltd (000059.SZ) - Profitability Metrics

Key profitability indicators for North Huajin Chemical Industries Co.,Ltd (000059.SZ) show clear deterioration through the first half and trailing twelve months (TTM) ending June 2025, driven by widening operating pressures and losses attributed to shareholders.

• Net loss attributable to shareholders (H1 2025): ¥989 million (increase in loss of 33.15% vs H1 2024).
• Net income margin (Q2 2025): -5.91% (deterioration of 186.89% year-over-year).
• EPS (TTM ending June 2025): -¥1.44 per share.
• ROA (TTM ending June 2025): -6.06%.
• ROE (TTM ending June 2025): -21.30%.
• Net profit margin (TTM ending June 2025): -5.69%.

For broader corporate context and background on strategy, ownership and how the business generates revenue, see: North Huajin Chemical Industries Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

North Huajin Chemical Industries Co.,Ltd (000059.SZ) - Debt vs. Equity Structure

Key balance-sheet metrics as of the latest reporting dates indicate a capital structure with moderate leverage, strong cash buffers and a market valuation that implies investor caution relative to enterprise value.

• Total assets (June 2025): 27.37 billion yuan
• Total liabilities (June 2025): 16.25 billion yuan
• Total equity (June 2025): 11.12 billion yuan
• Reported total debt: 8.14 billion yuan
• Cash and short-term investments: 8.08 billion yuan (cash reserves 6.49 billion yuan explicitly in short-term investments/cash combined)
• Net debt: ~0.06 billion yuan (effectively neutral)
• Debt-to-equity ratio: ~1.46
• Market capitalization (Oct 22, 2025): 8.27 billion yuan
• Enterprise value (Oct 22, 2025): 15.79 billion yuan

Implications for investors:

• The nominal debt-to-equity ratio of ~1.46 signals leverage is material but mitigated by cash reserves; net-debt neutrality reduces immediate refinancing risk.
• Large cash and short-term investments (8.08 billion yuan) equal nearly the total interest-bearing debt (8.14 billion yuan), supporting operational flexibility and potential for opportunistic capex or deleveraging.
• EV (15.79 billion) materially exceeds market cap (8.27 billion), implying debt and minority interests contribute meaningfully to valuation and that equity markets price in lower expectations or risk premia.
• Investors should weigh balance-sheet liquidity against cyclical exposures in chemicals and monitor covenant, maturities and working capital trends.

Context and further reading: Exploring North Huajin Chemical Industries Co.,Ltd Investor Profile: Who's Buying and Why?

North Huajin Chemical Industries Co.,Ltd (000059.SZ) - Liquidity and Solvency

Key metrics for the trailing twelve months (TTM) ending June 2025 and Q2 2025 performance highlight the company's short-term liquidity position, cash generation and changes in cash balances.

• Current ratio (TTM Jun 2025): 1.35 - adequate short-term liquidity to cover current liabilities.
• Quick ratio (TTM Jun 2025): 0.64 - indicates reliance on inventory to meet immediate obligations.
• Operating cash flow (TTM Jun 2025): ¥459.7 million - positive operational cash generation.
• Free cash flow (TTM Jun 2025): ¥2.78 billion - substantial cash available after capital expenditures.
• Cash flow from operations (Q2 2025): ¥2.47 billion - +132.96% YoY, signaling a strong operational improvement.
• Net change in cash (Q2 2025): ¥1.92 billion - +172.09% YoY, reflecting an increased cash position over the year.

Considerations from these figures:

• A current ratio of 1.35 provides a buffer for short-term obligations, but a quick ratio of 0.64 indicates inventory makes up a large portion of current assets.
• Strong free cash flow (¥2.78 billion) supports discretionary uses - deleveraging, dividend policy, M&A or reinvestment.
• Substantial YoY increases in Q2 cash flow from operations (+132.96%) and net change in cash (+172.09%) point to improved operating efficiency or working capital management.
• Monitor inventory turns and accounts receivable collection to assess whether quick ratio improvement is achievable without impairing sales.

Mission Statement, Vision, & Core Values (2026) of North Huajin Chemical Industries Co.,Ltd.

North Huajin Chemical Industries Co.,Ltd (000059.SZ) - Valuation Analysis

Key valuation metrics for the trailing-twelve-month (TTM) period ending June 2025 and market data through late 2025 indicate a cheaply valued name by several traditional measures but with negative earnings and moderate market risk.

• P/S (TTM Jun 2025): 0.24 - very low relative to revenue, implying investors pay ¥0.24 for each yuan of sales.
• P/B: 0.79 - stock trading below book value, suggesting potential asset-backed upside or reflect balance-sheet concerns.
• Beta: 0.804 - below-market volatility, less price sensitivity to market swings.
• EPS (TTM Jun 2025): -1.44 yuan - negative earnings per share, highlighting profitability pressure.
• Market Cap (Oct 22, 2025): ¥8.27 billion; Enterprise Value: ¥15.79 billion - EV materially above market cap, reflecting net debt and/or minority interests.
• Share price (Dec 12, 2025): ¥5.03; 52-week range: ¥4.20 - ¥5.85.

Practical considerations for investors:

• Low P/S and P/B suggest valuation upside if profitability recovers; negative EPS is the primary risk to watch.
• EV ≈ ¥15.79B vs. market cap ¥8.27B implies significant net debt or non-equity claims - assess leverage and interest burden.
• Beta ~0.80 can dampen headline volatility but does not mitigate idiosyncratic operational risk tied to chemical markets and margins.
• Monitor quarterly results post-June 2025 for EPS trajectory and working capital trends that affect EV and valuation multiples.

Further corporate context and strategic positioning: Mission Statement, Vision, & Core Values (2026) of North Huajin Chemical Industries Co.,Ltd.

North Huajin Chemical Industries Co.,Ltd (000059.SZ) - Risk Factors

Key financial signals through June and the first three quarters of 2025 highlight elevated risk for investors in North Huajin Chemical Industries Co.,Ltd (000059.SZ). The company posted sizable losses, weak profitability ratios, and a capital structure that leans on debt, all of which amplify operational, refinancing, and market risks.

• Liquidity risk: Quick ratio 0.64 indicates limited ability to meet immediate obligations; reliance on inventory or new financing to bridge shortfalls.
• Profitability risk: Negative net margin (-5.69%) and negative ROE (-21.30%) signal ongoing operating losses and capital erosion.
• Leverage/refinancing risk: Debt-to-equity ~1.46 creates vulnerability to rising interest rates and refinancing cycles; losses reduce covenant buffers.
• Non-recurring vs. recurring losses: Nearly identical net loss after removing non-recurring items (-1.413bn vs -1.394bn) shows losses stem largely from core operations, not one-offs.
• Market and demand risk: As a chemical producer, revenue volatility from raw material costs, end-market demand shifts, and price competition can exacerbate losses.
• Operational risk: Cost overruns, production disruptions, environmental/regulatory liabilities could further strain cash flows and increase contingent liabilities.

Additional investor considerations include covenant exposure, cash runway, and potential dilution from equity raises. For background on the company's broader profile and governance context, see: North Huajin Chemical Industries Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money

North Huajin Chemical Industries Co.,Ltd (000059.SZ) - Growth Opportunities

• Major JV: Panjin refinery and petrochemical complex with Aramco - project value > $10 billion, expected to drive downstream product diversification and scale.
• Market capitalization momentum: 8.27 billion yuan as of 2025-10-22, up 36.05% year-over-year, reflecting investor re-rating on growth prospects.
• Per-share revenue strength: Revenue per share (TTM ending 2025-06) of 21.01 yuan, indicating substantial top-line productivity per share.
• Robust cash generation: Operating cash flow (TTM ending 2025-06) of 459.7 million yuan and free cash flow of 2.78 billion yuan - positive operating liquidity with significant post-capex cash available.
• Equity market snapshot: Stock price 5.03 yuan as of 2025-12-12 with a 52-week range of 4.20-5.85 yuan, indicating upside potential if execution on the JV and cash deployment materializes.

• Value drivers: downstream integration from the Panjin complex, potential incremental EBITDA from higher-value petrochemical products, and improved feedstock economics via JV arrangements.
• Balance-sheet optionality: free cash flow of 2.78 billion yuan provides flexibility for capex allocation to JV phases, deleveraging, dividend policy or share buybacks.
• Market catalyst timeline: construction and commissioning milestones for the Panjin project, plus quarter-over-quarter operating cash flow trends, will be primary re-rating triggers.